| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Cadherin_tail | 3.41e-05 | 37 | 32 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 3.41e-05 | 37 | 32 | 3 | IPR031904 | |
| Domain | Cadherin_N | 1.86e-04 | 65 | 32 | 3 | IPR013164 | |
| Domain | Cadherin_2 | 1.86e-04 | 65 | 32 | 3 | PF08266 | |
| Domain | - | 2.19e-04 | 13 | 32 | 2 | 2.10.10.10 | |
| Domain | FN_type2_col-bd | 2.55e-04 | 14 | 32 | 2 | IPR000562 | |
| Domain | FN2_2 | 2.55e-04 | 14 | 32 | 2 | PS51092 | |
| Domain | fn2 | 2.55e-04 | 14 | 32 | 2 | PF00040 | |
| Domain | FN2_1 | 2.55e-04 | 14 | 32 | 2 | PS00023 | |
| Domain | FN2 | 2.55e-04 | 14 | 32 | 2 | SM00059 | |
| Domain | Cadherin_CS | 8.48e-04 | 109 | 32 | 3 | IPR020894 | |
| Domain | Cadherin | 9.41e-04 | 113 | 32 | 3 | PF00028 | |
| Domain | CADHERIN_1 | 9.41e-04 | 113 | 32 | 3 | PS00232 | |
| Domain | CADHERIN_2 | 9.66e-04 | 114 | 32 | 3 | PS50268 | |
| Domain | - | 9.66e-04 | 114 | 32 | 3 | 2.60.40.60 | |
| Domain | CA | 9.90e-04 | 115 | 32 | 3 | SM00112 | |
| Domain | Cadherin-like | 1.02e-03 | 116 | 32 | 3 | IPR015919 | |
| Domain | RICIN | 1.05e-03 | 28 | 32 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 1.05e-03 | 28 | 32 | 2 | PS50231 | |
| Domain | Cadherin | 1.07e-03 | 118 | 32 | 3 | IPR002126 | |
| Domain | Ricin_B_lectin | 1.20e-03 | 30 | 32 | 2 | IPR000772 | |
| Domain | Kringle-like | 1.37e-03 | 32 | 32 | 2 | IPR013806 | |
| Domain | Cadherin_C_2 | 2.35e-03 | 42 | 32 | 2 | PF16492 | |
| Domain | Cadherin_C | 2.35e-03 | 42 | 32 | 2 | IPR032455 | |
| Domain | Gal_Oxase/kelch_b-propeller | 4.58e-03 | 59 | 32 | 2 | IPR011043 | |
| Domain | Kelch_1 | 6.39e-03 | 70 | 32 | 2 | PF01344 | |
| Domain | Kelch_1 | 6.39e-03 | 70 | 32 | 2 | IPR006652 | |
| Domain | - | 6.93e-03 | 73 | 32 | 2 | 2.60.120.260 | |
| Domain | EGF_1 | 9.32e-03 | 255 | 32 | 3 | PS00022 | |
| Domain | EGF-like_CS | 9.92e-03 | 261 | 32 | 3 | IPR013032 | |
| Domain | Galactose-bd-like | 1.13e-02 | 94 | 32 | 2 | IPR008979 | |
| Pubmed | 3.19e-07 | 15 | 32 | 3 | 15640798 | ||
| Pubmed | 4.77e-07 | 17 | 32 | 3 | 29911975 | ||
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 5.72e-07 | 18 | 32 | 3 | 10662547 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 5.72e-07 | 18 | 32 | 3 | 15570159 | |
| Pubmed | 1.41e-06 | 24 | 32 | 3 | 24698270 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 2.00e-05 | 57 | 32 | 3 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.11e-05 | 58 | 32 | 3 | 30377227 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 11703922 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 12154121 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 3.40e-05 | 68 | 32 | 3 | 11230163 | |
| Pubmed | PRMT5 is essential for B cell development and germinal center dynamics. | 3.67e-05 | 10 | 32 | 2 | 30604754 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 4.04e-05 | 72 | 32 | 3 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 4.39e-05 | 74 | 32 | 3 | 10817752 | |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 4.49e-05 | 11 | 32 | 2 | 9655502 | |
| Pubmed | Co-expression of Tbx6 and Sox2 identifies a novel transient neuromesoderm progenitor cell state. | 4.49e-05 | 11 | 32 | 2 | 29084802 | |
| Pubmed | 4.94e-05 | 77 | 32 | 3 | 10835267 | ||
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 5.38e-05 | 12 | 32 | 2 | 10612399 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 5.54e-05 | 80 | 32 | 3 | 10716726 | |
| Pubmed | Effect of retinoic acid signaling on Wnt/beta-catenin and FGF signaling during body axis extension. | 7.41e-05 | 14 | 32 | 2 | 19539783 | |
| Pubmed | Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. | 7.41e-05 | 14 | 32 | 2 | 21396893 | |
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 21799763 | ||
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 35514236 | ||
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 16467359 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 1.80e-04 | 119 | 32 | 3 | 28625976 | |
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 16751104 | ||
| Pubmed | Rac1 mediates morphogenetic responses to intercellular signals in the gastrulating mouse embryo. | 2.24e-04 | 24 | 32 | 2 | 21693517 | |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 2.49e-04 | 336 | 32 | 4 | 31253590 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.05e-04 | 28 | 32 | 2 | 15347688 | |
| Pubmed | 3.08e-04 | 655 | 32 | 5 | 35819319 | ||
| Pubmed | Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling. | 3.51e-04 | 30 | 32 | 2 | 20630950 | |
| Pubmed | MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation. | 4.25e-04 | 33 | 32 | 2 | 32439762 | |
| Pubmed | Wnt5a and Wnt11 regulate mammalian anterior-posterior axis elongation. | 4.79e-04 | 35 | 32 | 2 | 25813538 | |
| Pubmed | 7.41e-04 | 193 | 32 | 3 | 22589738 | ||
| Interaction | PCDHA9 interactions | 1.75e-05 | 32 | 32 | 3 | int:PCDHA9 | |
| Cytoband | 5q31 | 7.20e-05 | 115 | 32 | 3 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.17e-03 | 298 | 32 | 3 | chr5q31 | |
| Cytoband | 6p21.1 | 1.44e-03 | 80 | 32 | 2 | 6p21.1 | |
| Cytoband | 17q11.2 | 2.69e-03 | 110 | 32 | 2 | 17q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.78e-03 | 404 | 32 | 3 | chr1q21 | |
| Cytoband | 1q21.3 | 3.04e-03 | 117 | 32 | 2 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 3.68e-03 | 129 | 32 | 2 | chr2q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q11 | 6.36e-03 | 171 | 32 | 2 | chr17q11 | |
| Cytoband | 16p11.2 | 7.87e-03 | 191 | 32 | 2 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 1.61e-02 | 278 | 32 | 2 | chr16p11 | |
| GeneFamily | Clustered protocadherins | 5.38e-05 | 64 | 21 | 3 | 20 | |
| GeneFamily | Fibronectin type III domain containing | 1.46e-02 | 160 | 21 | 2 | 555 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-07 | 199 | 32 | 5 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 7.99e-06 | 179 | 32 | 4 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.25e-05 | 118 | 32 | 3 | 9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-04 | 133 | 32 | 3 | 9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d | |
| ToppCell | mild_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 1.46e-04 | 143 | 32 | 3 | 4698cc877dda9b1ef7d6f18c9adc869ef791b1d8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 146 | 32 | 3 | d33bd571c2adf5f89e6f02e77d094c19edd4729c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 155 | 32 | 3 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 155 | 32 | 3 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 155 | 32 | 3 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 160 | 32 | 3 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 162 | 32 | 3 | 08b7f06580d516307516d5475a5dae0fa040f1a4 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 162 | 32 | 3 | 1fda21a303a08aff6f97819cd8766cd18784d8bc | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 162 | 32 | 3 | fc313fb2c55957faa8c9ca4023b3fce63527c267 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 162 | 32 | 3 | 002fac3c5c3030950f9eb9e887d59902586d8452 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 2.26e-04 | 166 | 32 | 3 | 20f248d95c86eb52a1efe9abe73123fbe4206caf | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-04 | 173 | 32 | 3 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-04 | 174 | 32 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.64e-04 | 175 | 32 | 3 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.64e-04 | 175 | 32 | 3 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-04 | 176 | 32 | 3 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 177 | 32 | 3 | a25ca82c4bda033ee113f8ecb4a541b22e7a29ca | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 177 | 32 | 3 | fbead6e56271b1f1d447f89857de444ebe7157b0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-4_RORB_FOLH1B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 178 | 32 | 3 | 22955b82917206aeed49dc0ac4630ccd9e51c4a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 178 | 32 | 3 | b0fc56f583cb3f2977fe2306994c0d478c9a6b1b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | 53e700494d251ec5649b2dea5fc7d5aeeeed572b | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 179 | 32 | 3 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.82e-04 | 179 | 32 | 3 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 182 | 32 | 3 | cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 2.96e-04 | 182 | 32 | 3 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 183 | 32 | 3 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 239cc5184825b3cc98638d4aec0a1de8e508d76c | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.16e-04 | 186 | 32 | 3 | 3314def702fe6a5056d0dadbb3a587c5d1a16412 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 186 | 32 | 3 | 1094c7140131454b2583200e1c01e81ccab3db23 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.31e-04 | 189 | 32 | 3 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.41e-04 | 191 | 32 | 3 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 08be56a4055a73c920d345fd3b2052a5ccb675d8 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | 35f7926628a967f85b26371e795a1b93c6f103ab | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.52e-04 | 193 | 32 | 3 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 3.52e-04 | 193 | 32 | 3 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 194 | 32 | 3 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.68e-04 | 196 | 32 | 3 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 196 | 32 | 3 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 3.73e-04 | 197 | 32 | 3 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.79e-04 | 198 | 32 | 3 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | severe-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.79e-04 | 198 | 32 | 3 | 88649dc642193bda5e8eff3f79c832807d5e200a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 7cea58e2691564e653cc972bf5aaff2df1f2666e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 193c42c31a366a60d80c4c1fc6a1592a5b01a3ad | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 7c780e995a5fc3793080da61b6bf7a12880e9df8 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)----L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | d0b31dc5eedc0635c0d7ceabaa6202386cf2a4a4 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-04 | 200 | 32 | 3 | 694ebc8cc14f80b6f2f4acec4ce7452d8b816af8 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 8444ae3c10b1152dec67ca812e6c417cc3b9cf89 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| Drug | H 296 | 8.55e-05 | 10 | 32 | 2 | CID003057981 | |
| Drug | fusarenon-X | 1.04e-04 | 11 | 32 | 2 | CID000031763 | |
| Drug | Ebna | 1.22e-04 | 183 | 32 | 4 | CID000018835 | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.38e-04 | 189 | 32 | 4 | 2967_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 6623_UP | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A | 1.55e-04 | 195 | 32 | 4 | 2004_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | 1.55e-04 | 195 | 32 | 4 | 1366_DN | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 5528_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A | 1.59e-04 | 196 | 32 | 4 | 1367_DN | |
| Drug | prednisolone; Down 200; 1uM; MCF7; HG-U133A | 1.59e-04 | 196 | 32 | 4 | 265_DN | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; HL60; HG-U133A | 1.59e-04 | 196 | 32 | 4 | 1606_DN | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 3027_DN | |
| Drug | Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A | 1.62e-04 | 197 | 32 | 4 | 1408_UP | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; HL60; HG-U133A | 1.62e-04 | 197 | 32 | 4 | 1742_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 1842_UP | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; HL60; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3136_UP | |
| Drug | Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 5731_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; HL60; HG-U133A | 1.65e-04 | 198 | 32 | 4 | 1977_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 2787_UP | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 7330_DN | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 1463_UP | |
| Drug | 5707885; Down 200; 50uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 6433_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 3641_DN | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; PC3; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 6333_UP | |
| Drug | SIRIUS | 1.72e-04 | 77 | 32 | 3 | CID000091750 | |
| Disease | visceral adipose tissue measurement, body mass index | 8.56e-05 | 87 | 29 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | 1,5 anhydroglucitol measurement | 3.72e-04 | 29 | 29 | 2 | EFO_0008009 | |
| Disease | Malignant neoplasm of breast | 5.31e-04 | 1074 | 29 | 6 | C0006142 | |
| Disease | Mammary Neoplasms, Human | 1.65e-03 | 525 | 29 | 4 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 1.65e-03 | 525 | 29 | 4 | C4704874 | |
| Disease | Mammary Neoplasms | 1.68e-03 | 527 | 29 | 4 | C1458155 | |
| Disease | Breast Carcinoma | 1.81e-03 | 538 | 29 | 4 | C0678222 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.95e-03 | 82 | 29 | 2 | EFO_0008535 | |
| Disease | neuroblastoma | 5.80e-03 | 116 | 29 | 2 | EFO_0000621 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NHDIGGFFEPGTWMR | 996 | P78357 | |
| MEPDGRGAWAHSRAA | 26 | Q99728 | |
| MSSGRRRGSAPWHSF | 1 | Q68DQ2 | |
| HEGWFMAFTRQGRPR | 146 | O60258 | |
| PDWRYSASLRAGMHS | 791 | Q9UN72 | |
| SSGHMWGTFRFERPD | 326 | Q9Y2S7 | |
| GSQRPFHRFDDVWPM | 161 | O00165 | |
| TGEDGHHWRVFRMGP | 171 | Q7Z465 | |
| WFFGPEMNSRRRHVG | 346 | Q9P2G9 | |
| PDWRYSASLRAGMHS | 861 | Q9Y5I4 | |
| PDWRYSASLRAGMHS | 801 | Q9UN74 | |
| GPSFIRSWTFGMFSD | 526 | Q52LW3 | |
| EIDRPGSFAWHMNRS | 1591 | Q9Y6J0 | |
| MDFLSPHGSAWDPSR | 476 | P15391 | |
| GDTWRRPHETGGYML | 151 | P02751 | |
| SIRPETHSPGMFSWF | 566 | O14744 | |
| MWGRFLAPEASGRDS | 1 | Q5SZL2 | |
| RARMAEPSFGGFWSA | 221 | P19235 | |
| PARWRDFHSATMLGS | 176 | Q9BQ90 | |
| MRAGWTPRGFSAFHA | 1 | Q9ULL0 | |
| AFWEHGASRAMLPGS | 381 | Q8WUF5 | |
| MFDFEGRHPSTFWQS | 106 | Q9Y2I2 | |
| SMEFGRAVWLRFHPS | 316 | P58872 | |
| SSRPSAFMVGGSVHW | 406 | P22732 | |
| AEPGSVAGRTSHMWF | 231 | Q9UHJ6 | |
| GTFSSFMPSAWRSRD | 331 | Q13018 | |
| SPDESHRMWRFSGQI | 331 | Q13610 | |
| MGGSPRALDRHWTSF | 266 | Q9H3T2 | |
| QHWGGMASFRFPETT | 231 | O95947 | |
| WTSGAGFSEMGRSRF | 66 | Q6ZWC4 | |
| RHGAFSSASDVWMFG | 296 | Q13470 | |
| LFTRDHMSGWCEGPR | 21 | Q5TGU0 | |
| DASGWAFRFPMGEFR | 876 | Q9UGR2 |